Abstract:There are many accepted airway clearance techniques (ACTs) for managing the respiratory health of people with cystic fibrosis (CF); none of which demonstrate superiority. Other Cochrane Reviews have reported short‐term effects related to mucus transport, but no evidence supporting long‐term benefits. Exercise is an alternative ACT thought to produce shearing forces within the lung parenchyma, which enhances mucociliary clearance and the removal of viscous secretions. Recent evidence suggests that some people with CF are using exercise as a substitute for traditional ACTs, yet there is no agreed recommendation for this. Additionally, one of the top 10 research questions identified by people with CF is whether exercise can replace other ACTs. Systematically reviewing the evidence for exercise as a safe and effective ACT will help people with CF decide whether to incorporate this strategy into their treatment plans and potentially reduce their treatment burden. The timing of this review is especially pertinent given the shifting landscape of CF management with the advent of highly‐effective small molecule therapies, which are changing the way people with CF are cared for. To compare the effect of exercise to other ACTs for improving respiratory function and other clinical outcomes in people with CF and to assess the potential adverse effects associated with this ACT. On 28 February 2022, we searched the Cochrane Cystic Fibrosis Trials Register, compiled from electronic database searches and handsearching of journals and conference abstract books. We also searched the reference lists of relevant articles and reviews. We searched online clinical trial registries on 15 February 2022. We emailed authors of studies awaiting classification or potentially eligible abstracts for additional information on 1 February 2021. We selected randomised controlled studies (RCTs) and quasi‐RCTs comparing exercise to another ACT in people with CF for at least two treatment sessions. Two review authors independently extracted data and assessed risk of bias for the included studies. They assessed the certainty of the evidence using GRADE. Review authors contacted investigators for further relevant information regarding their publications. We included four RCTs. The 86 participants had a wide range of disease severity (forced expiratory volume in one second (FEV 1 ) ranged from 54% to 95%) and were 7 to 41 years old. Two RCTs were cross‐over and two were parallel in design. Participants in one RCT were hospitalised with an acute respiratory exacerbation, whilst the participants in three RCTs were clinically stable. All four RCTs compared exercise either alone or in combination with another ACT, but these were too diverse to allow us to combine results. The certainty of the evidence was very low; we downgraded it due to low participant numbers and high or unclear risks of bias across all domains. Exercise versus active cycle of breathing technique (ACBT) One cross‐over trial (18 participants) compared exercise alone to ACBT. There was no change from baseline in our primary outcome FEV 1 , although it increased in the exercise group before returning to baseline after 30 minutes; we are unsure if exercise affected FEV 1 as the evidence is very low‐certainty. Similar results were seen for other measures of lung function. No adverse events occurred during the exercise sessions (very low‐certainty evidence). We are unsure if ACBT was perceived to be more effective or was the preferred ACT (very low‐certainty evidence). 24‐hour sputum volume was less in the exercise group than with ACBT (secondary outcome). Exercise capacity, quality of life, adherence, hospitalisations and need for additional antibiotics were not reported. Exercise plus postural drainage and percussion (PD&P) versus PD&P only Two trials (55 participants) compared exercise and PD&P to PD&P alone. At two weeks, one trial narratively reported a greater increase in FEV 1 % predicted with PD&P alone. At six months, the other trial reported a greater increase with exercise combined with PD&P, but did not provide data for the PD&P group. We are uncertain whether exercise with PD&P improves FEV 1 as the certainty of evidence is very low. Other measures of lung function did not show clear evidence of effect. One trial reported no difference in exercise capacity (maximal work rate) after two weeks. No adverse events were reported (1 trial, 17 participants; very low‐certainty evidence). Adherence was high, with all PD&P sessions and 96% of exercise sessions completed (1 trial, 17 participants; very low‐certainty evidence). There was no difference between groups in 24‐hour sputum volume or in the mean duration of hospitalisation, although the six‐month trial reported fewer hospitalisations due to exacerbations in the exercise -Abstract Truncated-

Effect of Exercise Training on Prognosis in Community-Acquired Pneumonia: A Randomised Controlled Trial

Effect of exercise training on functional ability, body composition, and physical activity in community-acquired pneumonia: secondary analysis of a randomised controlled trial

The efficacy of different training programs guided by cardiopulmonary exercise test goals for the treatment of male patients with chronic obstructive pulmonary disease

Early pulmonary rehabilitation after acute exacerbation of COPD: a randomised controlled trial

Exercise training initiated early during hospitalisation in individuals with chronic obstructive pulmonary disease is safe and improves exercise capacity and physical function at hospital discharge: A systematic review and meta-analysis

Efficacy of corticosteroid treatment for severe community-acquired pneumonia: A meta-analysis.

Do pulmonary rehabilitation programmes improve outcomes in patients with COPD posthospital discharge for exacerbation: a systematic review and meta-analysis

Clinical Effects of Exercise Combined with Respiratory Training in the Rehabilitation Treatment of Patients with Chronic Obstructive Pulmonary Disease.

Disease burden and prognostic factors for clinical failure in elderly community acquired pneumonia patients

Effects of Home-Based Pulmonary Training Program on Functional Exercise Capacity and Quality of Life in Patients with Chronic Obstructive Pulmonary Disease

Pulmonary rehabilitation for acute and stable COPD : a systematic review and network meta-analysis

Exercise rehabilitation in COPD and heart failure: comparison of two national audits

The short and long term effects of exercise training in non-cystic fibrosis bronchiectasis – a randomised controlled trial

Exercise versus airway clearance techniques for people with cystic fibrosis.

Exercise training for adults hospitalized with an acute respiratory condition: a systematic scoping review

Study protocol for evaluating the efficacy of early pulmonary rehabilitation combined with an internet-based patient management model in patients with COPD: a practical, multicentre, randomised controlled study from China

Short-course antibiotic therapy of 5 days in community-acquired pneumonia (CAP5): study protocol for a randomised controlled trial

Supervised pulmonary rehabilitation using minimal or specialist exercise equipment in COPD: a propensity-matched analysis

Early In-Bed Cycle Ergometry in Mechanically Ventilated Patients

Effectiveness of respiratory training in home-based pulmonary rehabilitation for elderly patients with stable COPD: Study protocol for a randomized controlled trial

Effect of nurse-led, goal-directed lung physiotherapy on prognosis of patients with sepsis caused by Acinetobacter baumannii pulmonary infection